About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Dengue or Japanese encephalitis?
Dr. Pallavi Sehgal
Email: pallavisehgal15@gmail.com
Corresponding Author:
Pallavi Sehgal1, Wasil Rasool Sheikh2, Dheeraj Nair1, Ankur Verma2, Sanjay Jaiswal2
1Department of Emergency Medicine, Max Super Superspeciality Hospital, Vaishali, UP, India; 2Department of Emergency Medicine, Max Super Speciality Hospital, Patparganj, New Delhi-110092, India.
Received: 15-MAY-2017 Accepted: 22-AUG-2017 Published Online: 30-AUG-2017
DOI: http://dx.doi.org/10.17659/01.2017.0080
Abstract
Background: Dengue and Japanese encephalitis are considered as one of the most common arbovirus diseases in tropics. Dengue virus has a wide spectrum of presentation starting from the classical dengue fever to dengue encephalitis and dengue shock syndrome. Moreover, Japanese encephalitis, which is one of the major public health problems in most of the South East Asian countries including India, may present with similar clinical picture mimicking dengue encephalitis. Case Report: We report the case of a 34 year old male patient who presented to the emergency department with complaints of fever and subsequently developed altered mental status. Investigations of the patient revealed dengue NS1 antigen positive but Magnetic Resonance Imaging findings were suggestive of Japanese encephalitis. Conclusion: Here, we discuss the likelihood of Dengue-Japanese encephalitis co-infection in endemic countries where both dengue and Japanese encephalitis are common. 
Keywords : Arboviruses, Dengue Virus, Fever, India, Japanese Encephalitis.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Dec 04, 2024